[Visceral leishmaniasis: a new oral treatment?]

Arch Pediatr. 1999 Jun;6(6):687-8. doi: 10.1016/s0929-693x(99)80305-4.
[Article in French]
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiprotozoal Agents / adverse effects
  • Antiprotozoal Agents / therapeutic use*
  • Child
  • Clinical Trials, Phase I as Topic
  • Clinical Trials, Phase II as Topic
  • Humans
  • Leishmaniasis, Visceral / drug therapy*
  • Phosphorylcholine / adverse effects
  • Phosphorylcholine / analogs & derivatives*
  • Phosphorylcholine / therapeutic use

Substances

  • Antiprotozoal Agents
  • Phosphorylcholine
  • miltefosine